DUBLIN, June 16, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/bqwbck/companion) has announced the addition of the "Companion Diagnostics Market (2nd Edition), 2014 - 2024" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The Companion Diagnostics Market (2nd Edition), 2014 - 2024' report provides an extensive study of the growing market of companion diagnostics. The report differentiates personalized medicine diagnostics and companion diagnostics; it has separately defined these two closely associated markets. The research covers various aspects, such as advantages of personalized medicine over traditional medicine and the need for companion diagnostics. In addition to evaluating the marketed and pipeline companion diagnostic tests, the report also includes views on the current state of the companion drugs market.
One of the key objectives of this report is to understand the future evolution of the companion diagnostics market. The proprietary Companion Diagnostics Market Forecasting Model' allows the likely growth of companion diagnostics tests across various parameters to be predicted. The model, built over a ten year horizon, offers valuable insights on the following:
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. COMPANION DRUGS MARKET, 2013
5. GLOBAL MARKET FOR COMPANION DIAGNOSTICS, 2014 - 2024
6. REGIONAL MARKET FOR COMPANION DIAGNOSTICS, 2014 - 2024
7. PROFILES OF LEADING COMPANIES
8. ANALYSIS OF THERANOSTICS MARKET: STAKEHOLDERS AND BUSINESS MODELS
9. MARKET GROWTH DRIVERS
10. INTERVIEW TRANSCRIPTS
11. CONCLUSION
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For more information visit http://www.researchandmarkets.com/research/bqwbck/companion
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article